1
|
Margariti A, Papakonstantinou VD, Stamatakis GM, Demopoulos CA, Machalia C, Emmanouilidou E, Schnakenburg G, Nika MC, Thomaidis NS, Philippopoulos AI. First-Row Transition Metal Complexes Incorporating the 2-(2'-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin. Molecules 2023; 28:6899. [PMID: 37836742 PMCID: PMC10574351 DOI: 10.3390/molecules28196899] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2023] [Revised: 09/26/2023] [Accepted: 09/28/2023] [Indexed: 10/15/2023] Open
Abstract
Inflammatory mediators constitute a recently coined term in the field of metal-based complexes with antiplatelet activities. Our strategy targets Platelet-Activating Factor (PAF) and its receptor, which is the most potent lipid mediator of inflammation. Thus, the antiplatelet (anti-PAF) potency of any substance could be exerted by inhibiting the PAF-induced aggregation in washed rabbit platelets (WRPs), which internationally is a well-accepted methodology. Herein, a series of mononuclear (mer-[Cr(pqx)Cl3(H2O]) (1), [Co(pqx)Cl2(DMF)] (2) (DMF = N,N'-dimethyl formamide), [Cu(pqx)Cl2(DMSO)] (3) (DMSO = dimethyl sulfoxide), [Zn(pqx)Cl2] (4)) and dinuclear complexes ([Mn(pqx)(H2O)2Cl2]2 (5), [Fe(pqx)Cl2]2 (6) and [Ni(pqx)Cl2]2 (7)) incorporating the 2-(2'-pyridyl)quinoxaline ligand (pqx), were biologically evaluated as inhibitors of the PAF- and thrombin-induced aggregation in washed rabbit platelets (WRPs). The molecular structure of the five-co-ordinate analog (3) has been elucidated by single-crystal X-ray diffraction revealing a trigonal bipyramidal geometry. All complexes are potent inhibitors of the PAF-induced aggregation in WRPs in the micromolar range. Complex (6) displayed a remarkable in vitro dual inhibition against PAF and thrombin, with IC50 values of 1.79 μM and 0.46 μM, respectively. Within the series, complex (5) was less effective (IC50 = 39 μM) while complex (1) was almost 12-fold more potent against PAF, as opposed to thrombin-induced aggregation. The biological behavior of complexes 1, 6 and 7 on PAF's basic metabolic enzymatic pathways reveals that they affect key biosynthetic and catabolic enzymes of PAF underlying the anti-inflammatory properties of the relevant complexes. The in vitro cytotoxic activities of all complexes in HEK293T (human embryonic kidney cells) and HeLa cells (cervical cancer cells) are described via the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. The results reveal that complex 3 is the most potent within the series.
Collapse
Affiliation(s)
- Antigoni Margariti
- Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece;
| | - Vasiliki D. Papakonstantinou
- Laboratory of Biochemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece; (V.D.P.); (G.M.S.); (C.A.D.); (C.M.); (E.E.)
| | - George M. Stamatakis
- Laboratory of Biochemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece; (V.D.P.); (G.M.S.); (C.A.D.); (C.M.); (E.E.)
| | - Constantinos A. Demopoulos
- Laboratory of Biochemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece; (V.D.P.); (G.M.S.); (C.A.D.); (C.M.); (E.E.)
| | - Christina Machalia
- Laboratory of Biochemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece; (V.D.P.); (G.M.S.); (C.A.D.); (C.M.); (E.E.)
| | - Evangelia Emmanouilidou
- Laboratory of Biochemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece; (V.D.P.); (G.M.S.); (C.A.D.); (C.M.); (E.E.)
| | - Gregor Schnakenburg
- Institut für Anorganische Chemie, Rheinische Friedrich-Wilhelms-Universität Bonn, Gerhard-Domagk-Straße 1, D-53121 Bonn, Germany;
| | - Maria-Christina Nika
- Laboratory of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece; (M.-C.N.); (N.S.T.)
| | - Nikolaos S. Thomaidis
- Laboratory of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece; (M.-C.N.); (N.S.T.)
| | - Athanassios I. Philippopoulos
- Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece;
| |
Collapse
|
2
|
Atukuri D. Pyrazolopyridine: An efficient pharmacophore in recent drug design and development. Chem Biol Drug Des 2022; 100:376-388. [PMID: 35661410 DOI: 10.1111/cbdd.14098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2022] [Revised: 05/25/2022] [Accepted: 05/29/2022] [Indexed: 11/29/2022]
Abstract
Among the various heterocyclic molecules employed for drug design and discovery, pyrazolopyridine is one of the promising pharmacophores. Pyrazolopyridine is a result of fusion of pyrazole and pyridine rings. The potent pharmacology of pyrazolopyridine may be the synergistic effect of pyrazole and pyridine moieties in a single framework. It has been used in drug design of a wide range of diseases such as anticancer, antimicrobial, anti-inflammatory, and neuroprotection. Cancer has become a common disease among elderly people now a days that might be because of genetic inheritance to some extent, carcinogens, pollution, and some infectious diseases. Whatever may be the reason, cancer is one of the major causes of deaths worldwide. In addition, over-usage and improper usage of antibiotics have led to drug resistance of microbes. Further, inflammation is a cause of various diseases such as arthritis, and other diseases. Thus, proinflammatory kinases are considered as primary target for inhibition of inflammation. In view of this, a work that compiles potent pharmacology of recently reported pyrazolopyridine analogs has been planned. The review is aimed to discuss pharmacology in brief along with structure-activity relationship (SAR). The review would emphasize importance of pyrazolopyridines in future drug design and discovery and may help in design of potent pharmacological agents.
Collapse
|
3
|
Kalampalidis A, Peppas A, Schnakenburg G, Papakyriakou A, Tsoupras A, Zabetakis I, Philippopoulos AI. Antithrombotic and antiplatelet activity of an organometallic rhodium(I) complex incorporating a substituted thieno‐[2,3‐
d
]‐pyrimidine ligand: Synthesis, structural characterization, and molecular docking calculations. Appl Organomet Chem 2021. [DOI: 10.1002/aoc.6210] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Affiliation(s)
- Alexandros Kalampalidis
- Laboratory of Inorganic Chemistry, Department of Chemistry National and Kapodistrian University of Athens Athens Greece
| | - Anastasios Peppas
- Laboratory of Inorganic Chemistry, Department of Chemistry National and Kapodistrian University of Athens Athens Greece
| | - Gregor Schnakenburg
- Institut für Anorganische Chemie Rheinische Friedrich‐Wilhelms‐Universität Bonn Bonn Germany
| | - Athanasios Papakyriakou
- Institute of Biosciences & Applications National Centre for Scientific Research “Demokritos” Athens Greece
| | - Alexandros Tsoupras
- Department of Biological Sciences University of Limerick Limerick Ireland
- Health Research Institute University of Limerick Limerick Ireland
- Bernal Institute University of Limerick Limerick Ireland
| | - Ioannis Zabetakis
- Department of Biological Sciences University of Limerick Limerick Ireland
- Health Research Institute University of Limerick Limerick Ireland
| | - Athanassios I. Philippopoulos
- Laboratory of Inorganic Chemistry, Department of Chemistry National and Kapodistrian University of Athens Athens Greece
| |
Collapse
|
4
|
da Silva Lima CH, de Araujo Vanelis Soares JC, de Sousa Ribeiro JL, Muri EMF, de Albuquerque S, Dias LRS. Anti-Trypanosoma cruzi Activity and Molecular Docking Studies of 1Hpyrazolo[ 3, 4-b]pyridine Derivatives. LETT DRUG DES DISCOV 2020. [DOI: 10.2174/1570180816666190305141733] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:
Untargeted studies led to the development of some pyrazolopyridine
derivatives for the antiparasitic profile, particularly the derivatives containing the structural
carbohydrazide subunit. In this work, we proceeded in the biological screening of 27 N’- (substitutedphenylmethylene)-
4-carbohydrazide-3-methyl-1-phenyl-1H-pyrazolo[3, 4-b]pyridine derivatives against
T. cruzi as well as the cytotoxic evaluation. To obtain more information about the trypanocidal
activity of this class of compounds, we carried out molecular docking simulations to get an insight
into putative targets in T. cruzi.
Methods:
The assays were evaluated against both trypomastigote and amastigote forms of T. cruzi
and cytotoxicity assays on LLCMK2 cells. The predominant conformational compounds were
analyzed and molecular docking simulations performed.
Results:
The results from trypanocidal activity screening of this series showed that just the
compounds with phenyl group at C-6 position exhibited activity and the N’-4-hydroxyphenylmethylene
derivative presented the best profile against both trypomastigote and amastigote
forms of T. cruzi. Docking simulation results showed that this compound has a binding affinity with
both CYP51 and cruzain targets of T. cruzi.
Conclusion:
Our results indicate that the hydroxyl substituent at the N’-substituted-phenylmethylene
moiety and the phenyl ring at C-6 of 1H-pyrazolo[3,4-b]pyridine system are relevant for the
trypanocidal activity of this class of compounds. Also, docking simulations showed that activity
presented can be related to more than one target of the parasite.
Collapse
Affiliation(s)
- Camilo Henrique da Silva Lima
- Laboratório de Quimica Medicinal, Universidade Federal Fluminense, Faculdade de Farmacia, Niteroi, Rio de Janeiro, Brazil
| | | | - Joana Lucius de Sousa Ribeiro
- Laboratório de Quimica Medicinal, Universidade Federal Fluminense, Faculdade de Farmacia, Niteroi, Rio de Janeiro, Brazil
| | - Estela Maris Freitas Muri
- Laboratório de Quimica Medicinal, Universidade Federal Fluminense, Faculdade de Farmacia, Niteroi, Rio de Janeiro, Brazil
| | - Sérgio de Albuquerque
- Universidade de Sao Paulo, Departamento de Analises Clinicas, Toxicologicas e Bromatologicas, Av. do Cafe s/n, Ribeirao Preto, SP, 14040-903, Brazil
| | - Luiza Rosaria Sousa Dias
- Laboratório de Quimica Medicinal, Universidade Federal Fluminense, Faculdade de Farmacia, Niteroi, Rio de Janeiro, Brazil
| |
Collapse
|
5
|
Ramzan A, Nazeer A, Irfan A, Al-Sehemi AG, Verpoort F, Khatak ZA, Ahmad A, Munawar MA, Khan MA, Basra MAR. Synthesis and Antiplatelet Potential Evaluation of 1,3,4-Oxadiazoles Derivatives. Z PHYS CHEM 2019. [DOI: 10.1515/zpch-2018-1316] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Abstract
A novel series of 2-(3-methyl-1,6-diphenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-5-aryl-1,3,4-oxadiazoles (4a–4h) has been synthesized from corresponding hydrazones (3a–3h) and evaluated their antiplatelet aggregation effect induced by arachidonic acid and collagen. Spectral data and elemental evaluation were used to confirm the structure of the compounds while molecular docking against cyclooxygenase 1 and 2 (COX1 & COX2) and quantitative structure-activity relationship (QSAR) were performed in describing their antiplatelet potential. All synthesized compound exhibited more than 50% platelet aggregation inhibition against both arachidonic acid and collagen. Antiplatelet activities results showed that 4b and 4f compounds have highest % inhibition against arachidonic acid. High Egap and ionization potential values showed that the compound 4d, 4e and 4f were supposed to be more active and good electron donor while 4b, 4c, 4d, 4e, 4g and 4h might be more active due to more electrophilic sites. Interaction with more than one residues in the binding pocket of COX-1 in comparison with aspirin and ligand efficacy (LE) consequences showed that compounds have excellent action potential for COX-1. Computational evaluations are in good agreement with antiplatelet activities of the compounds. All compounds might be promising antiplatelet agents especially 4b, 4f and helpful in the synthesis of new drugs for the treatment of cardiovascular diseases (CVDs).
Collapse
Affiliation(s)
- Ayesha Ramzan
- Institute of Chemistry, University of the Punjab, Quaid-e-Azam (New) Campus , Lahore 54590 , Pakistan
| | - Areesha Nazeer
- Institute of Chemistry, University of the Punjab, Quaid-e-Azam (New) Campus , Lahore 54590 , Pakistan
| | - Ahmad Irfan
- Department of Chemistry, Faculty of Science , King Khalid University , P.O. Box 9004, Abha 61413 , Saudi Arabia
| | - Abdullah G. Al-Sehemi
- Research Center for Advanced Materials Science (RCAMS), King Khalid University , P.O. Box 9004, Abha 61413 , Saudi Arabia
| | - Francis Verpoort
- Laboratory of Organometallics , Catalysis and Ordered Materials, State Key Laboratory of Advanced Technology for Material Synthesis and Processing, Wuhan University of Technology , Wuhan 430070 , China
| | - Zafar A. Khatak
- Laboratory of Organometallics , Catalysis and Ordered Materials, State Key Laboratory of Advanced Technology for Material Synthesis and Processing, Wuhan University of Technology , Wuhan 430070 , China
| | - Aftab Ahmad
- Center of Excellence in Molecular Biology, University of the Punjab , Lahore , Pakistan
| | - Munawar A. Munawar
- Institute of Chemistry, University of the Punjab, Quaid-e-Azam (New) Campus , Lahore 54590 , Pakistan
| | - Misbahul A. Khan
- Institute of Chemistry, University of the Punjab, Quaid-e-Azam (New) Campus , Lahore 54590 , Pakistan
- Department of Chemistry , The Islamia University of Bahawalpur , Bahawalpur 63100 , Pakistan , Tel./Fax: +96-42-99230463 Ext. 839
| | - Muhammad Asim Raza Basra
- Institute of Chemistry, University of the Punjab, Quaid-e-Azam (New) Campus , Lahore 54590 , Pakistan , e-mail:
| |
Collapse
|
6
|
Antiplatelet activity, molecular docking and QSAR study of novel N′-arylmethylidene-3-methyl-1-phenyl-6-p-chlorophenyl-1H-pyrazolo[3,4-b] pyridine-4-carbohydrazides. Med Chem Res 2017. [DOI: 10.1007/s00044-017-2053-0] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
7
|
Lourenço AL, Salvador RRS, Silva LA, Saito MS, Mello JFR, Cabral LM, Rodrigues CR, Vera MAF, Muri EMF, de Souza AMT, Craik CS, Dias LRS, Castro HC, Sathler PC. Synthesis and mechanistic evaluation of novel N'-benzylidene-carbohydrazide-1H-pyrazolo[3,4-b]pyridine derivatives as non-anionic antiplatelet agents. Eur J Med Chem 2017; 135:213-229. [PMID: 28453995 DOI: 10.1016/j.ejmech.2017.04.023] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2017] [Revised: 03/27/2017] [Accepted: 04/11/2017] [Indexed: 12/13/2022]
Abstract
Cardiovascular diseases (CVDs) account for over 17 million deaths globally each year, with atherosclerosis as the underlying cause of most CVDs. Herein we describe the synthesis and in vitro mechanistic evaluation of novel N'-benzylidene-carbohydrazide-1H-pyrazolo[3,4-b]pyridines (3-22) designed as non-anionic antiplatelet agents and presenting a 30-fold increase in potency compared to aspirin. The mechanism underlying their antiplatelet activity was elucidated by eliminating potential targets through a series of in vitro assays including light transmission aggregometry, clot retraction, and quantitative ELISA, further identifying the reduction in biosynthesis of thromboxane B2 as their main mechanism of action. The intrinsic fluorescence of the compounds permits their binding to platelet membranes to be readily monitored. In silico structure-activity relationship, molecular docking and dynamics studies support the biological profile of the series revealing the molecular basis of their activity and their potential as future molecular therapeutic agents.
Collapse
Affiliation(s)
- André L Lourenço
- Programa de Pós-Graduação em Patologia - Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Niterói, RJ, Brazil; Department of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA
| | - Raquel R S Salvador
- Programa de Pós-Graduação em Ciências Aplicadas a Produtos para Saúde (PPG-CAPS) - Faculdade de Farmácia, Universidade Federal Fluminense, Niterói, RJ, Brazil
| | - Leonardo A Silva
- Programa de Pós-Graduação em Ciências e Biotecnologia (PPBI) - Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ, Brazil
| | - Max S Saito
- Programa de Pós-Graduação em Patologia - Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Niterói, RJ, Brazil
| | - Juliana F R Mello
- Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF) - Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, RJ, Brazil
| | - Lúcio M Cabral
- Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF) - Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, RJ, Brazil
| | - Carlos R Rodrigues
- Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF) - Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, RJ, Brazil
| | - Maria A F Vera
- Laboratório de Química Medicinal (LQMed) - Faculdade de Farmácia, Universidade Federal Fluminense, Niterói, RJ, Brazil
| | - Estela M F Muri
- Laboratório de Química Medicinal (LQMed) - Faculdade de Farmácia, Universidade Federal Fluminense, Niterói, RJ, Brazil
| | - Alessandra M T de Souza
- Programa de Pós-Graduação em Ciências Aplicadas a Produtos para Saúde (PPG-CAPS) - Faculdade de Farmácia, Universidade Federal Fluminense, Niterói, RJ, Brazil
| | - Charles S Craik
- Department of Pharmaceutical Chemistry, University of California, San Francisco, CA, USA
| | - Luiza R S Dias
- Programa de Pós-Graduação em Ciências Aplicadas a Produtos para Saúde (PPG-CAPS) - Faculdade de Farmácia, Universidade Federal Fluminense, Niterói, RJ, Brazil; Laboratório de Química Medicinal (LQMed) - Faculdade de Farmácia, Universidade Federal Fluminense, Niterói, RJ, Brazil.
| | - Helena C Castro
- Programa de Pós-Graduação em Patologia - Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Niterói, RJ, Brazil; Programa de Pós-Graduação em Ciências e Biotecnologia (PPBI) - Instituto de Biologia, Universidade Federal Fluminense, Niterói, RJ, Brazil.
| | - Plínio C Sathler
- Programa de Pós-Graduação em Ciências Farmacêuticas (PPGCF) - Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, RJ, Brazil.
| |
Collapse
|
8
|
Saito MS, Lourenço AL, Dias LRS, Freitas ACC, Vitorino MI, Albuquerque MG, Rodrigues CR, Cabral LM, Dias EP, Castro HC, Satlher PC. Antiplatelet pyrazolopyridines derivatives: pharmacological, biochemical and toxicological characterization. J Enzyme Inhib Med Chem 2016; 31:1591-601. [DOI: 10.3109/14756366.2016.1158712] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Max Seidy Saito
- Laboratório de Antibióticos, Bioquímica, Ensino e Modelagem Molecular (LABiEMol) – Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil,
- Programa de Pós-Graduação em Patologia (PPG-UFF) – Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Niterói, Brazil,
| | - André Luiz Lourenço
- Laboratório de Antibióticos, Bioquímica, Ensino e Modelagem Molecular (LABiEMol) – Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil,
- Programa de Pós-Graduação em Patologia (PPG-UFF) – Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Niterói, Brazil,
| | - Luiza Rosaria Sousa Dias
- Laboratório de Química Medicinal (LQMed) – Faculdade de Farmácia, Universidade Federal Fluminense, Niterói, Brazil,
| | | | - Maíra Ingrid Vitorino
- Laboratório de Antibióticos, Bioquímica, Ensino e Modelagem Molecular (LABiEMol) – Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil,
| | | | | | - Lúcio Mendes Cabral
- Laboratório de Tecnologia Industrial Farmacêutica (LabTIF) – Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | - Eliane Pedra Dias
- Programa de Pós-Graduação em Patologia (PPG-UFF) – Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Niterói, Brazil,
| | - Helena Carla Castro
- Laboratório de Antibióticos, Bioquímica, Ensino e Modelagem Molecular (LABiEMol) – Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil,
- Programa de Pós-Graduação em Patologia (PPG-UFF) – Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Niterói, Brazil,
| | - Plínio Cunha Satlher
- Laboratório de Antibióticos, Bioquímica, Ensino e Modelagem Molecular (LABiEMol) – Instituto de Biologia, Universidade Federal Fluminense, Niterói, Brazil,
- Laboratório de Tecnologia Industrial Farmacêutica (LabTIF) – Faculdade de Farmácia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| |
Collapse
|
9
|
Aleixo de Carvalho LS, Geraldo RB, de Moraes J, Silva Pinto PL, de Faria Pinto P, Pereira ODS, Da Silva Filho AA. Schistosomicidal activity and docking of Schistosoma mansoni ATPDase 1 with licoflavone B isolated from Glycyrrhiza inflata (Fabaceae). Exp Parasitol 2015; 159:207-14. [DOI: 10.1016/j.exppara.2015.09.015] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2015] [Revised: 08/20/2015] [Accepted: 09/27/2015] [Indexed: 11/25/2022]
|
10
|
A facile synthesis of regioisomeric 4-amino- and 6-amino-3-arylpyrazolo[3,4-b]pyridine-5-carbonitriles. MENDELEEV COMMUNICATIONS 2015. [DOI: 10.1016/j.mencom.2015.09.023] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
11
|
Zhou C, Kang D, Xu Y, Zhang L, Zha X. Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking. Chem Biol Drug Des 2014; 85:659-71. [DOI: 10.1111/cbdd.12461] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2014] [Revised: 09/01/2014] [Accepted: 10/15/2014] [Indexed: 12/24/2022]
Affiliation(s)
- Chen Zhou
- State Key Laboratory of Natural Medicines; China Pharmaceutical University; Nanjing 210009 China
- Jiangsu Center for Drug Screening; China Pharmaceutical University; Nanjing 210009 China
- Department of Medicinal Chemistry; China Pharmaceutical University; Nanjing 210009 China
| | - Di Kang
- State Key Laboratory of Natural Medicines; China Pharmaceutical University; Nanjing 210009 China
- Jiangsu Center for Drug Screening; China Pharmaceutical University; Nanjing 210009 China
- Department of Medicinal Chemistry; China Pharmaceutical University; Nanjing 210009 China
| | - Yungen Xu
- State Key Laboratory of Natural Medicines; China Pharmaceutical University; Nanjing 210009 China
- Department of Medicinal Chemistry; China Pharmaceutical University; Nanjing 210009 China
| | - Luyong Zhang
- State Key Laboratory of Natural Medicines; China Pharmaceutical University; Nanjing 210009 China
- Jiangsu Center for Drug Screening; China Pharmaceutical University; Nanjing 210009 China
| | - Xiaoming Zha
- State Key Laboratory of Natural Medicines; China Pharmaceutical University; Nanjing 210009 China
- Jiangsu Center for Drug Screening; China Pharmaceutical University; Nanjing 210009 China
| |
Collapse
|
12
|
Sathler PC, Lourenço AL, Rodrigues CR, da Silva LCRP, Cabral LM, Jordão AK, Cunha AC, Vieira MCB, Ferreira VF, Carvalho-Pinto CE, Kang HC, Castro HC. In vitro and in vivo analysis of the antithrombotic and toxicological profile of new antiplatelets N-acylhydrazone derivatives and development of nanosystems. Thromb Res 2014; 134:376-83. [DOI: 10.1016/j.thromres.2014.05.009] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2013] [Revised: 04/04/2014] [Accepted: 05/06/2014] [Indexed: 11/24/2022]
|
13
|
Petrov AA, Kasatochkin AN, Emelina EE, Haukka M. Regioisomeric 4-amino- and 6-aminopyrazolo[3,4-b]pyridines: synthesis and structure determination by NMR spectroscopy and X-ray diffraction. Russ Chem Bull 2012. [DOI: 10.1007/s11172-012-0125-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|